Global Tumor Ablation Market Forecast & Regional Analysis 2023

  • ID: 4393798
  • Report
  • Region: Global
  • 110 Pages
  • Kuick Research
1 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BSD Medicals
  • Halyard Health
  • Medtronic Inc.
  • Misonix Inc.
  • ProstaLund
  • MORE

Tumor ablation is an emerging cancer therapy method that is gaining steady and wide acceptance as a successful cancer therapeutic.  Tumor ablation is a method that ensured higher efficacy of tumor cell treatment with minimum toxicity or side effects.  This form of treatment involves the destruction of tumors using heat, low temperature and chemical agents that are introduced into the tumor regions using a guided needle through a small hole.

Tumor ablation therapy proves to be an excellent option over other conventional methods of treatment due to its minimum invasiveness. It has been considered to be the best alternative in patients who cannot undergo surgery for medical reasons. It has proven to be highly effective and safe in the treatment of patients having four or few tumors limited to a small region, for larger and greater number of tumors, chemotherapy is considered much more effective. 
 
Global Tumor Ablation Market Forecast & Regional Analysis 2023 Report Highlights:

  • Exploring the Commercial Aspects of Tumor Ablation Therapy
  • Recent Advances in Tumor Ablation Therapy
  • Demand & Features of the Tumor Ablation Therapy
  • Technological Aspect of Tumor Ablation Therapy
  • Technology, Devices & Tools Involved in Tumor Ablation Therapy
  • Clinical Status of Tumor Ablation Therapy in Various Cancer Types
  • Global Tumor Ablation Therapy Market by Region, Technology & Mode of Treatment

The tumor ablation therapy segment has shown impressive improvements since it was first accepted as a therapeutic with current tumor ablation being more advanced and accurate, further causing much lesser trauma to patient. It also shows faster recovery and lesser time than the other existing invasive procedures.  The tumor ablation therapy is widely being accepted as a minimally invasive cancer therapeutic, which has thus led to the formation of a whole new market based on tumor ablation with global research and development contributing immensely in the growth and expansion of the market. Further, innovation in the resources and technology required in the tumor ablation has opened up ample opportunities for various pharmaceutical and electronics company to work for the betterment of the currently available technology for tumor ablation.

Over the years, tumor ablation therapy market has shown immense improvements in all of its segments. Our analysis clearly indicates that tumor ablation technology and devices market is currently the most profitable market leading all other ablation segments with major contribution from the radiofrequency ablation technology. The early and timely introduction of radiofrequency ablation technology, when an effective alternative for tumor surgery was required has been the prime reason for its dominance in the tumor ablation therapy market. The overall market opportunity for Tumor ablation therapy is expected to surpass US$ 1.2 Billion by 2023.

The high success rate of tumor ablation has been one of the promoting factors of the novel therapeutic, thus making it one of the most preferable tumor therapies where other therapeutics might not be feasible for multiple reasons. The tumor ablation technique has been used for the treatment of various types of cancer such as liver cancer, lung cancer, prostate cancer, colorectal cancer etc.

The ongoing technical innovations have made tumor ablation procedure safe and painless with impressive results during and after treatment. With rising awareness in the healthcare industry all over the world, cancer ablation is steadily getting popular as one of the most preferred method of cancer therapy for various types of cancer. Hospitals and healthcare centers realize the immense potential that cancer ablation therapy has, thus providing the facility to their patients which would further help in promoting the therapeutic.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Angiodynamics
  • BSD Medicals
  • Halyard Health
  • Medtronic Inc.
  • Misonix Inc.
  • ProstaLund
  • MORE

1. Tumor Ablation - A Minimally Invasive Cancer Therapeutic
1.1 Prologue to Tumor Ablation Therapy
1.2 History & Progress of Tumor Ablation Therapy

2. Demand & Features of the Tumor Ablation Therapy
2.1 Dire Need for a Safe & Non-Invasive Cancer Therapy
2.2 Compelling Features of the Tumor Ablation Therapy

3. Tumor Ablation - Providing an Edge over Existing Cancer Therapeutics
3.1 Direct Tumoricidal Effect
3.2 Minimal Invasive Therapy
3.3 Affordability
3.4 Applicable to a Non-surgical Candidate
3.5 Swift Procedure With Faster Recovery
3.6 Can be Repeated Multiple Times

4. Technological Aspect of Tumor Ablation Therapy

5. Radiofrequency Ablation Therapy
5.1 Overview
5.2 Therapeutic Mechanism of Radiofrequency Ablation

6. Microwave Tumor Ablation Therapy
6.1 The Physics of Microwave & its Therapeutic Mechanism
6.2 Superiority of Microwave Ablation Therapy Compared to Radiofrequency Ablation Therapy

7. Cryoablation Therapy
7.1 Cryoablation Therapy - An Emerging Modern Cancer Ablation Procedure
7.2 Procedure, Mechanism & Clinical Applications of Cryoablation Therapy

8. High Intensity Focused Ultrasound (HIFU)
8.1 An Insight into the Progress of HIFU over the Last Decade
8.2 Working Mechanism of High Intensity Focused Ultrasound

9. Other Tumor Ablation Therapeutics
9.1 Laser Induced Thermal Therapy for Tumor Ablation
9.2 Irreversible Electroporation Ablation (IER)

10. Tumor Ablation Types by Mode of Treatment
10.1 Surgical Ablation of Tumors
10.2 Laparoscopic Tumor Ablation
10.3 Percutaneous Tumor Ablation

11. Technology, Devices & Tools Involved in Tumor Ablation Therapy
11.1 Imaging Technologies
11.1.1 Computed Tomography
11.1.2 Magnetic Resonance Imaging (MRI)
11.2 Catheters or Probes

12. Clinical Status of Tumor Ablation Therapy in Various Cancer Types
12.1 Primary Hepatocellular Carcinoma (HCC)
12.2 Non-Small Cell Lung Cancer
12.3 Renal (Kidney Tumor Ablation)
12.4 Prostate Cancer
12.5 Breast Cancer
12.6 Bone Metastasis
12.7 Pancreas

13. Recent Advances in Tumor Ablation Therapy

14. Exploring the Commercial Aspects of Tumor Ablation Therapy
14.1 Cost Benefit Analysis of Tumor Ablation Therapy
14.2 Tumor Ablation Cost Analysis
14.2.1 Common Cost of Tumor Lesion Treatment Using any of the Available Ablation Modalities
14.2.2 Modality Specific Ablation Cost for a 3cm Kidney Lesion

15. Global Tumor Ablation Therapy Market Current Scenario
15.1 Tumor Ablation Market by Technology
15.2 Tumor Ablation Therapy Market by Mode of Treatment
15.3 Tumor Ablation Market by Application

16. Tumor Ablation Therapy Market by Region
16.1 North America
16.2 Europe
16.3 Asia Pacific
16.4 Rest of the World

17. Global Tumor Ablation Therapy Market Dynamics
17.1 Driving Factors of the Tumor Ablation Market
17.2 Restraining Factors in the Growth of Tumor Ablation Therapy Market

18. Anticipation Regarding the Future of Tumor Ablation Therapy Market

19. Competitive Landscape
19.1 Angiodynamics
19.2 Boston Scientific
19.3 Galil Medicals
19.4 INTIO Inc.
19.5 Medtronic Inc.
19.6 Misonix Inc.
19.7 NeuWave Medical Inc.
19.8 SonaCare Medical
19.9 Medwaves
19.10 BSD Medicals
19.11 ProstaLund
19.12 Halyard Health

List of Figures:
Figure 1-1: Evolution of Tumor Ablation Therapy
Figure 2-1: Desired Characteristic of an Ideal Ablation Therapy
Figure 3-1: Superiority of Tumor Ablation over Other Cancer Therapeutics
Figure 4-1: Tumor Ablation Technology Types
Figure 5-1: Thermal Destruction of Tumor using RFA
Figure 5-2: Radiofrequency Ablation Therapy Clinical Setup
Figure 6-1: Principle of Microwave Ablation
Figure 6-2: Advantages of Microwave Ablation over Radiofrequency Ablation
Figure 7-1: Increasing the Efficacy of Cryoablation by Nanoparticle-Encapsulated Doxorubicin (n-DOX)
Figure 8-1: High Intensity Focused Ultrasound in Action
Figure 9-1: Irreversible Electroporation Ablation in Action
Figure 10-1: Tumor Ablation Types by Mode of Treatment
Figure 11-1: Imaging Technologies Used in Tumor Ablation
Figure 11-2: Various Types of Probes Used in Tumor Ablation
Figure 12-1: Radiofrequency Ablation in Treatment of Liver Tumor
Figure 12-2: Cryoablation Therapy for Renal Cancer
Figure 14-1: Cost of Various Ablation Therapeutics (US$), 2016
Figure 15-1: Global - Tumor Ablation Market Segmentation
Figure 15-2: Global - Increase in the Number of Geriatric Population (Billion), 1990-2050
Figure 15-3: Global - Tumor Ablation Therapy Market by Region (%), 2016
Figure 15-4: Global - Tumors Ablation Modalities Market Share (%), 2016
Figure 15-5: Global - Radiofrequency Ablation Device Market (US$ Million), 2015-2023
Figure 15-6: Global - Microwave Ablation Therapy Device Market (US$ Million), 2015-2023
Figure 15-7: Global - Cryoablation Therapy Device Market (US$ Million), 2015-2023
Figure 15-8: Global - Tumor Ablation Market by Treatment Modality (%), 2016
Figure 15-9: Number of Patients Undergoing Tumor Ablation Therapy (‘000), 2016
Figure 16-1: North America - Tumor Ablation Therapy Market (US$ Million), 2015-2023
Figure 16-2: North America - Radiofrequency Ablation Device Market (US$ Million), 2015-2023
Figure 16-3: North America - Microwave Ablation Therapy Device Market (US$ Million), 2015-2023
Figure 16-4: North America - Cryoablation Therapy Device Market (US$ Million), 2015-2023
Figure 16-5: North America - Tumor Ablation Therapy by Mode of Treatment, 2016
Figure 16-6: Europe - Tumor Ablation Therapy Market (US$ Million), 2015-2023
Figure 16-7: Europe- Regional Tumor Ablation Therapy Market Share (%), 2016
Figure 16-8: Europe - Tumor Ablation Therapy by Mode of Treatment (%), 2016
Figure 16-9: Asia - Tumor Ablation Therapy by Treatment (%), 2016
Figure 16-10: Asia -Tumor Ablation Therapy Market (US$ Million), 2015-2023
Figure 16-11: Rest of the world- Tumor Ablation Therapy Market (US$ Million), 2015-2023
Figure 17-1: Global - Driving Factors of the Tumor Ablation Therapy Market
Figure 17-2: Cancer - Global Prevalence (‘000), 2015
Figure 17-3: Global - Challenging Factors of the Tumor Ablation Therapy
Figure 18-1: Global - Future Aspects of Tumor Ablation Therapy

List of Tables:
Table 14-1: Tumor Ablation Cost by Modalities (2016)
Table 14-2: Tumor Ablation Cost for Kidney Lesion

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Angiodynamics
  • Boston Scientific
  • BSD Medicals
  • Galil Medicals
  • Halyard Health
  • INTIO Inc.
  • Medtronic Inc.
  • Medwaves
  • Misonix Inc.
  • NeuWave Medical Inc.
  • ProstaLund
  • SonaCare Medical
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll